Dallas-based healthcare company Tenet Healthcare Corp. has appointed industry leader Vineeta Agarwala, M.D., Ph.D., to its board of directors, effective immediately.
“We are pleased to welcome Dr. Vineeta Agarwala to the Tenet board,” Saum Sutaria, M.D., Tenet chairman and CEO, said in a statement. “Vineeta is a leader in healthcare in her own right. Her expertise in innovative technologies, including applications of artificial intelligence, will enhance our governance in a rapidly evolving healthcare marketplace.”
Agarwala will serve as a member of the Quality, Compliance, and Ethics Committee, as well as the Human Resources Committee, increasing the size of the board to 13 directors, Tenet said.
She is a general partner at Andreessen Horowitz (a16z), where she leads investments for the firm’s Bio + Health fund across biotech and digital health, Tenet said. Agarwala focuses on partnering with companies leveraging unique technologies and datasets to advance drug development, personalized medicine, and novel approaches to patient care delivery.
Agarwala’s experience includes research at the prestigious Broad Institute in computational biology and human genetics. She completed her clinical residency at Stanford and is board certified in internal medicine.
Tenet is a diversified healthcare services company whose care delivery network includes United Surgical Partners International, the largest ambulatory platform in the country, which operates or has ownership interests in more than 480 ambulatory surgery centers and surgical hospitals.
The company operates 61 acute care and specialty hospitals, approximately 110 other outpatient facilities, a network of leading employed physicians and a global business center in Manila, Philippines.
Tenet’s Conifer Health Solutions subsidiary provides revenue cycle management and value-based care services to hospitals, health systems, physician practices, employers, and other clients.
Get on the list.
Dallas Innovates, every day.
Sign up to keep your eye on what’s new and next in Dallas-Fort Worth, every day.
R E A D N E X T
-
"Since data is crucial for maintaining ongoing DEIB initiatives and dedication, Kanarys leads the way in establishing quantifiable DEIB strategies, thanks to its data-centric methodology aimed at creating a fairer future for all work settings," says Google CDO and Kanary's Board Member Melonie Parker.
-
Tenet Healthcare Corp. of Dallas announced that former U.S. Sen. Roy Blunt has been appointed to the Tenet board of directors. Blunt will serve as a member of the Audit Committee, Nominating and Corporate Governance Committee, and Environmental, Social, and Governance Committee. The company said that his appointment expands the board to 12 directors, 11 of whom are independent members. “We are pleased to welcome Senator Roy Blunt as a new board member,” Tenet CEO Saum Sutaria, M.D., said in a statement. “With more than 25 years of legislative experience, Roy’s expertise in public policy and addressing cross-cutting issues will…
-
Uniting two health tech innovators, Dallas-based unicorn Axxess has strategically acquired Complia Health, accelerating its quest to revolutionize home health tech solutions for providers.
-
A1 Health Ventures is a newly launched VC firm developed jointly between Abundant Venture Partners and First Trust Capital Partners. Its director, Joe Greskoviak, joins Dallas-based Prolucent's board following a $4 million investment, which will fuel Prolucent's "continued product innovation."
-
Dallas-Fort Worth is well known for its tech expertise. Now it being recognized as the place where technology meets life science—a convergence that's driving rapid growth in the biotech ecosystem. Leaders in the industry attribute this success to the unique convergence of the region's exceptional tech talent pool and cutting-edge developments in life science. The area has seen groundbreaking advancements in areas ranging from genetic engineering to cancer treatment to eco-restoration. Dr. Hubert Zajicek, CEO, Partner, and Co-Founder of Health Wildcatters, is among a group of local biotech leaders who see Dallas' strength in technology and its role in the…
